Health Discovery Corporation

Equities

HDVY

US42218R1005

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:24:37 2024-04-02 pm EDT			5-day change	1st Jan Change
0.00001 ^USD	-90.00%		0.00%	-90.00%

2023	Health Discovery Corporation Announces Retirement of William F. Fromholzer from the Board of Directors	CI
2023	Health Discovery Corporation Announces Demise of George Mcgovern, Chairman	CI

Health Discovery Corporation Reports Earnings Results for the Full Year Ended December 31, 2019

May 12, 2020 at 05:03 pm EDT

Health Discovery Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was USD 1.518 million compared to USD 44,300 a year ago. Operating income was USD 78,453 compared to operating loss of USD 769,620 a year ago. Net income was USD 1.560 million compared to net loss of USD 795,474 a year ago.

Latest news about Health Discovery Corporation

Health Discovery Corporation Announces Retirement of William F. Fromholzer from the Board of Directors	23-10-17	CI
Health Discovery Corporation Announces Demise of George Mcgovern, Chairman	23-07-05	CI
Health Discovery Corporation Announces Demise of George Mcgovern, Chief Executive Officer	23-07-05	CI
Health Discovery Corporation Announces Board Changes	22-10-26	CI
Health Discovery Corporation Announces Resignation of Marty Delmonte as President, Chief Operating Officer and Director	22-06-22	CI
Health Discovery Corporation announced that it expects to receive $0.41 million in funding	22-03-29	CI
Health Discovery Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Health Discovery Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Health Discovery Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Health Discovery Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-19	CI
Health Discovery Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Health Discovery Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Health Discovery Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-30	CI
Health Discovery Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-12	CI
Health Discovery Corporation Appoints Mr. Marty Delmonte as President and Chief Operating Officer	20-04-10	CI
Health Discovery Corporation announced that it has received $0.2 million in funding	19-04-21	CI
Health Discovery Corporation Announces Board Appointments	18-05-15	CI
Health Discovery Corporation Announces Resignation of Kevin Kowbel as Director	18-03-23	CI
Health Discovery Corporation announced that it has received $0.3 million in funding	17-10-22	CI
Health Discovery Corporation Appoints Edward Morrison to the Board of Directors	17-05-02	CI
Health Discovery Corporation Announces Board Changes	17-04-11	CI
Health Discovery Corporation Announces Management Changes	17-03-02	CI
Henry S. Kaplan Resigns from the Board of Directors of Health Discovery Corporation	16-10-19	CI
Health Discovery Corporation Auditor Raises 'Going Concern' Doubt	15-03-30	CI
Health Discovery Corporation Announces Resignation of John Norris as Director	13-10-17	CI

Chart Health Discovery Corporation

Duration

Period

More charts

Company Profile

Health Discovery Corporation (HDC) is an intellectual property development company that uses mathematical techniques to analyze data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the field of molecular diagnostics where such tools are used for scientific discovery. Its Support Vector Machine (SVM) assets in particular have applicability in various other fields. HDC's joint venture, SVM Capital, LLC (SVM Capital), applies SVM technology to the financial markets. The Company's principal asset is its intellectual property, which includes mathematical algorithms called SVM and Fractal Genomic Modeling (FGM), as well as biomarkers that the Company has developed by applying its SVM and FGM techniques to genetic and proteomic data. It also owns the assets of Fractal Genomics, LLC, a company with FGM software. The FGM data analysis technique enables the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
HEALTH DISCOVERY CORPORATION	-90.00%	4.2K
EXACT SCIENCES CORPORATION	-20.55%	10.82B
IOVANCE BIOTHERAPEUTICS, INC.	+47.97%	3.25B
GUARDANT HEALTH, INC.	-32.75%	2.11B
BGI GENOMICS CO., LTD.	-14.15%	2.08B
VERACYTE, INC.	-26.06%	1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+19.85%	1.02B
SEEGENE, INC.	-2.62%	733M
CAREDX, INC	-31.67%	391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-43.88%	383M

Bio Diagnostics & Testing